Diem Nguyen
Fortune : 732 487 $ au 31/05/2026
Fortune : 732 487 $ au 31/05/2026
Diem Nguyen is currently Chief Executive Officer & Director at SIGA Technologies, Inc. since 2024.
Dr. Nguyen serves as Independent Director at Candel Therapeutics, Inc. since 2021 and at Verrica Pharmaceuticals, Inc. since 2020.
Dr. Nguyen is Director at Vitara Biomedical, Inc. and Trustee at The Children's Hospital of Philadelphia.
Former roles include President, Chief Executive Officer & Director at Xalud Therapeutics, Inc. from 2020 to 2024; Executive Vice President-Biopharma at PPD, Inc. from 2018 to 2020; Global President-Americas at Pfizer Essential Health from 2017 to 2018; and Senior Director-Corporate Development at Serologicals Corp.
from 2004 to 2006.
Education includes undergraduate and doctorate degrees from the University of Virginia and an MBA from the University of Virginia Darden School of Business, conferred in 1999.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SIGA TECHNOLOGIES INC 0,19 % | 17/04/2026 | 138 767 ( 0,19 % ) | 649 430 $ | 31/05/2026 |
| 24/04/2026 | 10 000 ( 0,01 % ) | 83 000 $ | 31/05/2026 | |
| 05/06/2026 | 10 ( 0 % ) | 58 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| VERRICA PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 09/06/2020 |
| CANDEL THERAPEUTICS, INC. | Directeur/Membre du Conseil | 15/07/2021 |
| SIGA TECHNOLOGIES, INC. | Directeur Général | 27/01/2024 |
The Children's Hospital of Philadelphia
The Children's Hospital of Philadelphia Hospital/Nursing ManagementHealth Services Operates hospitals | Directeur/Membre du Conseil | - |
Vitara Biomedical, Inc.
Vitara Biomedical, Inc. Packaged SoftwareTechnology Services Develops therapeutic platform | Directeur/Membre du Conseil | 01/07/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
Xalud Therapeutics, Inc.
Xalud Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company advancing a non-viral plasmid DNA delivered gene therapy platform to treat pathologic inflammation | Directeur Général | 01/01/2024 |
| PPD, INC. | Corporate Officer/Principal | 01/04/2020 |
Pfizer Essential Health
Pfizer Essential Health Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/03/2018 |
Serologicals Corp.
Serologicals Corp. Miscellaneous Commercial ServicesCommercial Services Researches, develops and markets biological products | Corporate Officer/Principal | 01/07/2006 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 11 |
|---|---|
Serologicals Corp.
Serologicals Corp. Miscellaneous Commercial ServicesCommercial Services Researches, develops and markets biological products | Commercial Services |
SIGA Technologies, Inc.
SIGA Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines and antibiotics | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Candel Therapeutics, Inc.
Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
University of Virginia Darden School of Business
University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Children's Hospital of Philadelphia
The Children's Hospital of Philadelphia Hospital/Nursing ManagementHealth Services Operates hospitals | Health Services |
Xalud Therapeutics, Inc.
Xalud Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company advancing a non-viral plasmid DNA delivered gene therapy platform to treat pathologic inflammation | Health Technology |
Verrica Pharmaceuticals, Inc.
Verrica Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
PPD, Inc.
PPD, Inc. BiotechnologyHealth Technology Engages in research and development of biopharmaceutical industry | Health Technology |
Pfizer Essential Health
Pfizer Essential Health Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Vitara Biomedical, Inc.
Vitara Biomedical, Inc. Packaged SoftwareTechnology Services Develops therapeutic platform | Technology Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national